Recall archive / FDA drug enforcement
Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepac... — FDA record D-1538-2022
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Sep 15, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00
- Reason
- Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
- Classification
- Class II
- Recalling firm
- RemedyRepack Inc.
- Quantity
- 1,699 blister cards/30 tablets each
- Agency-reported status
- Terminated
- Source record identifier
- D-1538-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot # J0636336-073022, J0637605-080422, Exp. date 08/31/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Distributed to two direct accounts in PA and AK.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Sep 21, 2022
- Recall initiation date
- Sep 15, 2022
- Center classification date
- Sep 15, 2022
- Termination date
- Nov 16, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.